ENTITY
Kyowa Kirin Co Ltd

Kyowa Kirin Co Ltd (4151 JP)

48
Analysis
Health CareJapan
Kyowa Hakko Kirin Co.,Ltd. develops, manufactures, and markets pharmaceuticals. The Company's products include a protein produced by genetic recombination technology, an anti-anemia agent that attaches new sugar chains through partial modification of the amino acid sequence of human erythropoietin (EPO), and a glycoprotein, human erythropoietin.
more
bullishKirin Holdings
09 Jun 2022 15:32

Kirin: Holdco Trade Has More Room to Run, Also Outright Attractive

Almost 12 months down the line, our Holdco trade involving Kirin has given us a return of around 33.3% against Topix’s 3.8% and Nikkei’s 2.6%...

Logo
312 Views
Share
bullishKirin Holdings
07 Dec 2021 16:04

Kirin: Holdco Discount Is Starting to Unwind Alongside The Return of Institutional Investors

Even though Kirin's listed holdings have gained more than 200% since 2019, Kirin's share price has failed to reflect that significant increase in...

Logo
300 Views
Share
24 Sep 2021 21:49

Global Energy Sector Improving -- Buying Reliance Industries Ltd, Several Others

Crude oil prices display bullish short-term reversals, resulting in bullish price and RS reversals for global Energy stocks -- add exposure.

Logo
430 Views
Share
bullishKirin Holdings
11 Aug 2021 18:52

Kirin: An End to Troubles in Myanmar JV Could Unwind the Multi-Year Low Holdco Discount

Kirin is currently trading at ¥1,982 per share, 5.5% above the past 52 week low just 7.2% above the COVID sell-off level. The market value of...

Logo
236 Views
Share
bullishMoney Forward
11 Jul 2021 23:27

July TOPIX FFW Rebalancing Trade

The TOPIX July FFW rebalance is large this year, on what is generally an overlooked rebalance trade. There are several multi-hundred million...

Logo
464 Views
Share
x